| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/17/2011 | WO2010123527A3 Use of epidermal growth factor inhibitors in the treatment of viral infection |
| 02/17/2011 | WO2010111565A3 Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
| 02/17/2011 | WO2010046289A3 Blockers of light, ltalpha1beta2 and ltalpha2beta1 or their receptor ltbetar for the prevention and treatment of chronic hepatitis and other liver diseases |
| 02/17/2011 | US20110041194 I-msoi homing endonuclease variants having novel substrate specificity and use thereof |
| 02/17/2011 | US20110041190 Novel chimeric proteins |
| 02/17/2011 | US20110040259 Method for allogeneic cell therapy |
| 02/17/2011 | US20110040249 Human Anti-IL-23 Antibodies, Compositions, Methods and Uses |
| 02/17/2011 | US20110039943 Methods for treating skin disorders with topical nitrogen mustard compositions |
| 02/17/2011 | US20110039918 Single Nucleotide Polymorphisms (SNPs) in Genes Associated with Inflammatory Diseases |
| 02/17/2011 | US20110039915 IMMUNOSTIMULATORY siRNA MOLECULES |
| 02/17/2011 | US20110039906 Antibacterial combination therapy |
| 02/17/2011 | US20110039884 Imidazopyridinones |
| 02/17/2011 | US20110039854 Linear and cyclic guanidine derivatives, method of preparation and uses thereof |
| 02/17/2011 | US20110039849 5-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection |
| 02/17/2011 | US20110039842 Compounds having antiviral properties |
| 02/17/2011 | US20110039840 Spirocyclic derivatives as histone deacetylase inhibitors |
| 02/17/2011 | US20110039836 Tricyclic antibiotics |
| 02/17/2011 | US20110039823 Oxazolidinone antibiotics |
| 02/17/2011 | US20110039816 Therapeutic substance, pharmaceutical composition, helicobacter pylori growth inhibitor and method for conducting anti-helicobacter therapy |
| 02/17/2011 | US20110039803 Solid forms of an anti-hiv phosphoindole compound |
| 02/17/2011 | US20110039800 Prolonged release bioadhesive therapeutic systems |
| 02/17/2011 | US20110039798 Substituted nucleoside derivatives with antiviral and antimicrobial properties |
| 02/17/2011 | US20110039797 Oligomer Conjugates of Heteropentacyclic Nucleosides |
| 02/17/2011 | US20110039765 Bioactive Molecules Produced by Probiotic Bacteria |
| 02/17/2011 | US20110039764 Therapeutic composition for bone infectious disease |
| 02/17/2011 | US20110039763 Targeted antimicrobial moieties |
| 02/17/2011 | US20110039762 Targeted antimicrobial moieties |
| 02/17/2011 | US20110039761 Targeted antimicrobial moieties |
| 02/17/2011 | US20110039760 Multimeric forms of antimicrobial peptides |
| 02/17/2011 | US20110038956 Selenium-containing compositions and uses thereof |
| 02/17/2011 | US20110038952 Gambogic acid glycoside derivatives and analogs, their preparation methods and applications |
| 02/17/2011 | US20110038938 Compositions for tissue augmentation |
| 02/17/2011 | US20110038935 Antibodies against influenza virus and methods of use thereof |
| 02/17/2011 | US20110038919 Textile materials with adhesive and methods for use thereof |
| 02/17/2011 | US20110038917 Therapeutic compositions and methods for treating gram-negative bacterial infections |
| 02/17/2011 | US20110038916 Sanitizers |
| 02/17/2011 | US20110038912 Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces |
| 02/17/2011 | US20110038910 Anti-infective antimicrobial-containing biomaterials |
| 02/17/2011 | US20110038908 Formulations and methods employing anhydrous disinfectant |
| 02/17/2011 | US20110038896 Biodegradable immunomodulatory formulations and methods for use thereof |
| 02/17/2011 | US20110038890 Cellular And Viral Inactivation |
| 02/17/2011 | US20110038886 N-Linked Glycosylation Alteration in E0 and E2 Glycoprotein of Classical Swine Fever Virus and Novel Classical Swine Fever Virus Vaccine |
| 02/17/2011 | US20110038885 Chemokine analogs |
| 02/17/2011 | US20110038884 Immunopotentiating agent comprising ep1 agonist |
| 02/17/2011 | US20110038879 Immunogenic and therapeutic compositions for streptococcus pyogenes |
| 02/17/2011 | US20110038870 Compositions and methods to enhance the immune system |
| 02/17/2011 | US20110038866 Improved fibronectin-based binding molecules and uses thereof |
| 02/17/2011 | US20110038852 Antivirals that target transporters, carriers, and ion channels |
| 02/17/2011 | US20110038833 Modified fluorinated nucleoside analogues |
| 02/17/2011 | US20110038809 Growth control of oral and superficial microorganisms using gallium compounds |
| 02/17/2011 | US20110038790 Treatment and prophylaxis of amyloidosis |
| 02/17/2011 | DE102010002210A1 Composition, useful in a feedstuff, comprises mussel biomass, smectite mineral compound and water, where the smectite mineral compound comprises specified amounts of smectite and amorphous silicon dioxide |
| 02/17/2011 | CA2771105A1 Compositions and methods for the therapy and diagnosis of influenza |
| 02/17/2011 | CA2770790A1 Vaccine having a peptide adjuvant for eliciting a specific immune response to treat viral infection and other conditions |
| 02/17/2011 | CA2770737A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use |
| 02/17/2011 | CA2764236A1 Compositions and methods for treating fungal infection of the nail |
| 02/16/2011 | EP2284268A2 Conserved HBV and HCV sequences useful for gene silencing |
| 02/16/2011 | EP2284192A2 Camelidae antibodies for sublingual administration |
| 02/16/2011 | EP2284190A2 Transfer factor from birds eggs |
| 02/16/2011 | EP2284174A1 Intermediates for the preparation of benzoxazine derivatives and process for their preparation |
| 02/16/2011 | EP2284164A2 Substituted tetracycline compounds |
| 02/16/2011 | EP2284156A2 Substituted tetracycline compounds |
| 02/16/2011 | EP2284155A2 Substituted tetracycline compounds |
| 02/16/2011 | EP2284153A2 Substituted tetracycline compounds |
| 02/16/2011 | EP2284152A2 Substituted tetracycline compounds |
| 02/16/2011 | EP2284151A2 Substituted tetracycline compounds |
| 02/16/2011 | EP2284150A2 Substituted tetracycline compounds |
| 02/16/2011 | EP2283897A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283896A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283872A2 Non-covalent bioconjugates useful for diagnosis and therapy |
| 02/16/2011 | EP2283869A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283868A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283865A1 Method of increasing testosterone and related steroid concentrations in women |
| 02/16/2011 | EP2283860A2 Use for interleukin-33 (il-33) and the il-33 receptor complex |
| 02/16/2011 | EP2283857A1 Vaccine composition comprising conjugated native N. Meningitidis capsular polysaccharides |
| 02/16/2011 | EP2283855A2 Polypeptides et polynucleotides de phorphorymonas gingivalis |
| 02/16/2011 | EP2283854A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 02/16/2011 | EP2283853A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 02/16/2011 | EP2283852A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 02/16/2011 | EP2283845A1 Sustained release drug delivery system containing codrugs |
| 02/16/2011 | EP2283835A2 Method and preparation for treating metabolic stress |
| 02/16/2011 | EP2283815A1 Propellant-free non polar buccal spray of a sedative |
| 02/16/2011 | EP2283814A1 Polar buccal spray of a sedative |
| 02/16/2011 | EP2283813A1 Propellant-free polar buccal spray of a sedative |
| 02/16/2011 | EP2283812A2 Topical antiviral formulations |
| 02/16/2011 | EP2283151A2 Dihydroorotate dehydrogenase as antifungal drug target and quinazolinone-based inhibitors thereof |
| 02/16/2011 | EP2283130A1 DISPERSINBtm, 5-FLUOROURACIL, DEOXYRIBONUCLEASE I AND PROTEINASE K-BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF |
| 02/16/2011 | EP2283033A1 Antiviral cell penetrating peptides |
| 02/16/2011 | EP2283018A1 Hepatitis c virus inhibitors |
| 02/16/2011 | EP2283006A1 Pyrrole antifungal agents |
| 02/16/2011 | EP2283002A2 Novel inhibitors of hepatitis c virus replication |
| 02/16/2011 | EP2282777A1 Topical combinations comprising an antimycotic agent and an antiviral agent |
| 02/16/2011 | EP2282771A1 Nanoparticles for use in pharmaceutical compositions |
| 02/16/2011 | EP2282730A1 Methods of treating fungal infections |
| 02/16/2011 | EP1931696B1 Arylalkyl and heteroarylalkyl derivatives of cyclosporine a for the treatment and prevention of viral infection |
| 02/16/2011 | EP1902719B1 Agent exhibiting bactericidal action with respect to vegetative and spore cells bacillus anthracis and its use for anthrax prevention and treatiment |
| 02/16/2011 | EP1835021B1 Novel strain conferring anti-disease properties to host and bacterial cell composition |
| 02/16/2011 | EP1577388B1 Adiponectin promoter and use thereof |
| 02/16/2011 | CN201743945U Cold preventing plaster |
| 02/16/2011 | CN1946420B Immunising against meningococcal serogroup y using proteins |